REPLICEL LIFE SCIENCES INC. Issued Capital
REPLICEL LIFE SCIENCES INC. had Issued Capital of CAD 31.66 million as of 2022-12-31, per its 20-F filed 2023-05-02.
Discontinued › Notes
ifrs-full:IssuedCapital · last filed 2023-05-02
- 2022-12-31: Issued Capital 31.66M CAD.
- 2021-12-31: Issued Capital 30.29M CAD.
- 2020-12-31: Issued Capital 28.47M CAD.
- 2019-12-31: Issued Capital 27.53M CAD; Issued Capital as first filed 28.96M CAD.
| Period end | Issued Capital | Issued Capital as first filed |
|---|---|---|
| 2022-12-31 | 31.66M CAD 20-F · filed 2023-05-02 | |
| 2021-12-31 | 30.29M CAD 20-F · filed 2023-05-02 | |
| 2020-12-31 | 28.47M CAD 20-F/A · filed 2022-09-13 | |
| 2019-12-31 | 27.53M CAD 20-F · filed 2021-05-17 | 28.96M CAD 20-F · filed 2020-08-05 |
| 2019-06-30 | 27.57M CAD 20-F/A · filed 2021-03-31 | |
| 2019-03-31 | 27.57M CAD 20-F/A · filed 2021-03-31 | |
| 2018-12-31 | 27.08M CAD 20-F/A · filed 2021-03-31 | 28.75M CAD 20-F · filed 2019-04-30 |
| 2017-12-31 | 26.18M CAD 20-F · filed 2019-04-30 | |
| 2016-12-31 | 21.91M CAD 20-F · filed 2018-05-11 |